A practical healthcare marketing governance framework for claims, privacy, reviews, endorsements, platform policy, and campaign controls.

Reviewed October 2026
Healthcare marketing compliance is a campaign-by-campaign governance process, not a label a practice can apply to its entire marketing program. A responsible program reviews each proposed claim, audience, channel, data flow, testimonial, vendor, and platform requirement before launch. HIPAA may be one part of that review, but it is not the only one. Consumer-protection rules, professional and state requirements, platform policies, contract terms, and internal standards can also matter.
This guide offers general information for healthcare marketing and operations teams. It is not legal advice or a determination that a campaign, claim, or technology is compliant. A practice’s qualified legal, privacy, security, compliance, and clinical leaders should decide which requirements apply to its services, jurisdictions, and marketing plans.
Start every material campaign with a simple record that states the audience, objective, service line, geography, channels, claims, creative, landing page, data collected, technology vendors, proposed budget, approval owners, and launch date. This makes it possible to identify what changed, who approved it, and which rule set applies.
Assign one accountable business owner and define the reviewers needed for the campaign. A general brand campaign may need a marketing, claims, and platform review. A campaign using patient data, appointment information, condition-based segmentation, a portal, or sensitive tracking may also need privacy, security, compliance, legal, and technical review. Avoid the false choice between moving quickly and reviewing carefully. A predictable approval workflow makes both possible.
Do not use HIPAA as a catch-all for every marketing concern. HIPAA questions focus on whether the organization is regulated, whether PHI is involved, what use or disclosure is proposed, and how vendors and safeguards are governed. Separate guides should cover those questions in depth because the answer depends on the actual communication and data flow.
Other campaigns may raise different issues even when they do not use PHI. These can include the accuracy of advertising claims, endorsements and reviews, professional and state requirements, contract terms, consumer privacy law, intellectual-property rights, platform eligibility, and audience targeting rules. The right response is not to label every idea safe or prohibited. It is to document the relevant questions, identify the owner, and obtain the appropriate review before publication.
For PHI, marketing authorization, tracking, vendors, and risk-based safeguards, use the related HIPAA and healthcare digital marketing guide. For a hands-on site inventory, use the healthcare website tracking audit.
Every objective claim should have a source, scope, owner, and approval record. This includes clinical or health-benefit claims, provider credentials, experience, availability, cost, financing, response time, patient outcomes, ranking statements, savings, satisfaction, and comparative claims. Review the full impression created by the headline, visuals, testimonial, qualification, offer, and call to action. A carefully worded sentence can still create an unsupported implication when paired with dramatic imagery or a broad promise.
FTC guidance on health-related advertising says that claims must be truthful, not misleading, and supported by adequate substantiation before dissemination. The appropriate support depends on the claim and context. Health benefit and safety claims generally require competent and reliable scientific evidence. Qualifying information must be clear and material, not buried in a disclaimer that conflicts with the overall message.
Do not turn a limited study, a result from a different population, an isolated patient story, or a vendor assertion into a universal promise. If a claim needs important limitations to remain accurate, present those limitations clearly. If the practice cannot support an objective claim, narrow it to a supportable statement or remove it.
Testimonials and reviews should reflect genuine experiences. Do not create, buy, sell, or disseminate fake or false reviews or testimonials, and do not suppress or selectively present feedback in a way that misleads consumers. FTC guidance emphasizes that material connections between an advertiser and an endorser should be clearly and conspicuously disclosed when they are not otherwise apparent to consumers. Maintain an internal record of the source of each testimonial, whether compensation or another material connection exists, the approval date, and the evidence supporting any performance statement associated with it.
A patient story, photo, video, direct message, or review response can also involve PHI. Do not publicly confirm that a person is a patient or disclose facts about their care in a response. If a practice plans to use patient information in marketing, it should obtain the appropriate authorization when required and have qualified reviewers assess the content and use case. A positive review does not give a practice permission to disclose the reviewer’s health information.
Before-and-after imagery and outcome-focused copy deserve the same evidence review as written claims. Ask what a reasonable prospective patient will infer, whether the result is typical or otherwise qualified, and whether the image, caption, service, patient population, and evidence genuinely match.
Platform approval is not a legal or HIPAA determination. It also is not guaranteed. Google Ads states that some healthcare and medicine content cannot be advertised, while other categories may be permitted only in certain locations or for advertisers that have applied and been approved. Its restrictions and certification requirements vary by the product or service and by targeted geography.
Before activating paid search, paid social, video advertising, or an influencer program, review the current policy for the actual service, location, audience, keyword, creative, landing page, and advertiser status. Record the policy source, owner, approval date, and contingencies. Update the review when the platform changes its rules or the campaign changes its product, targeting, claims, or destination.
Do not claim that an ad will be approved or that a particular feature is available in every market. Build a fallback plan that protects the reader experience and business objective if a platform limits delivery, rejects a creative, or changes eligibility requirements.
New tools can change a campaign’s data flow even when the creative remains the same. Before adding a tag, pixel, conversion API, form provider, chat tool, scheduling widget, call-tracking platform, customer-data integration, AI assistant, or audience feature, document what data is collected, where it is sent, who can access it, why it is needed, and which reviewer owns the decision.
Use a separate approval gate for AI-assisted content and automation. Identify the intended task, approved inputs, human reviewer, allowed claims, source requirements, disclosure requirements when applicable, escalation limits, and publishing authority. Do not put patient information or unapproved sensitive data into a tool simply because it makes content production or campaign management faster.
For the HIPAA-specific analysis of PHI, tracking, business-associate relationships, authorizations, and security safeguards, use the HIPAA and healthcare digital marketing guide.
Review high-impact campaigns before launch and on a defined schedule after launch. Recheck claims when new evidence, service changes, or pricing changes occur. Recheck platform policies before relaunching older creative. Recheck vendors, integrations, access, and tracking after website releases, agency changes, or new tool adoption. Keep the approval record with the creative, landing page, source material, vendor record, and final configuration.
If a concern is discovered, preserve relevant records and route it through the organization’s established privacy, security, legal, and incident-response processes. Do not decide that a campaign is lawful, unlawful, or a reportable incident based solely on a single tool finding or a generic checklist.
The practice’s qualified decision-makers should determine the applicable legal, privacy, clinical, and platform requirements. Contact Patient10x to discuss whether its services may be a fit for your marketing-governance needs.
FTC: Health Products Compliance Guidance
FTC: Endorsements, Influencers, and Reviews